Barely Significant
← all excerpts

In vivo anti-V-ATPase antibody treatment delays ovarian tumor growth by increasing antitumor immune responses.

Mol Oncol · 2020 · PMC7530789 · PMID 32797726

Europe PMCDOI
1
hedged sentence
0.0900
closest p · 1.8× alpha
0.0900
boldest claim

The sentences

showed a trendP = 0.09so close (0.05 < p ≤ 0.1)
CXCl‐9, the chemokine that mediates lymphocytic infiltration to the focal sites and suppresses tumor growth, also showed a trend toward upregulated expression (10.1‐fold, P = 0.09).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.